Global Irritable Bowel Syndrome (IBS) Market Research Report 2024(Status and Outlook)

Global Irritable Bowel Syndrome (IBS) Market Research Report 2024(Status and Outlook)



Report Overview:

Irritable bowel syndrome (IBS) is defined as recurrent abdominal pain or discomfort that occurs in association with altered bowel habits over a period of at least 3 months. The disorder is classified into three main subtypes, according to the predominant bowel habits presented: constipation-predominant IBS (IBS-C), diarrhea-predominant IBS (IBS-D), and mixed-presentation IBS (IBS-M). IBS is among the most common gastrointestinal disorders, with an estimated pooled international IBS prevalence rate of about 11.2%.

The Global Irritable Bowel Syndrome (IBS) Market Size was estimated at USD 2052.32 million in 2023 and is projected to reach USD 4747.15 million by 2029, exhibiting a CAGR of 15.00% during the forecast period.

This report provides a deep insight into the global Irritable Bowel Syndrome (IBS) market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.

The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Irritable Bowel Syndrome (IBS) Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.

In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Irritable Bowel Syndrome (IBS) market in any manner.

Global Irritable Bowel Syndrome (IBS) Market: Market Segmentation Analysis

The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.

Key Company

Bausch Health

Allergan

Takeda

Sucampo Pharmaceuticals (Mallinckrodt)

Sebela Pharmaceuticals Inc

Astellas Pharmaceuticals

Market Segmentation (by Type)

IBS-D Drug

IBS-C Drug

Others

Market Segmentation (by Application)

Women

Men

Geographic Segmentation

North America (USA, Canada, Mexico)

Europe (Germany, UK, France, Russia, Italy, Rest of Europe)

Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)

South America (Brazil, Argentina, Columbia, Rest of South America)

The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)

Key Benefits of This Market Research:

Industry drivers, restraints, and opportunities covered in the study

Neutral perspective on the market performance

Recent industry trends and developments

Competitive landscape & strategies of key players

Potential & niche segments and regions exhibiting promising growth covered

Historical, current, and projected market size, in terms of value

In-depth analysis of the Irritable Bowel Syndrome (IBS) Market

Overview of the regional outlook of the Irritable Bowel Syndrome (IBS) Market:

Key Reasons to Buy this Report:

Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change

This enables you to anticipate market changes to remain ahead of your competitors

You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents

The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly

Provision of market value (USD Billion) data for each segment and sub-segment

Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market


1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Irritable Bowel Syndrome (IBS)
1.2 Key Market Segments
1.2.1 Irritable Bowel Syndrome (IBS) Segment by Type
1.2.2 Irritable Bowel Syndrome (IBS) Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Irritable Bowel Syndrome (IBS) Market Overview
2.1 Global Market Overview
2.1.1 Global Irritable Bowel Syndrome (IBS) Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Irritable Bowel Syndrome (IBS) Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Irritable Bowel Syndrome (IBS) Market Competitive Landscape
3.1 Global Irritable Bowel Syndrome (IBS) Sales by Manufacturers (2019-2024)
3.2 Global Irritable Bowel Syndrome (IBS) Revenue Market Share by Manufacturers (2019-2024)
3.3 Irritable Bowel Syndrome (IBS) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Irritable Bowel Syndrome (IBS) Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Irritable Bowel Syndrome (IBS) Sales Sites, Area Served, Product Type
3.6 Irritable Bowel Syndrome (IBS) Market Competitive Situation and Trends
3.6.1 Irritable Bowel Syndrome (IBS) Market Concentration Rate
3.6.2 Global 5 and 10 Largest Irritable Bowel Syndrome (IBS) Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Irritable Bowel Syndrome (IBS) Industry Chain Analysis
4.1 Irritable Bowel Syndrome (IBS) Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Irritable Bowel Syndrome (IBS) Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Irritable Bowel Syndrome (IBS) Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Irritable Bowel Syndrome (IBS) Sales Market Share by Type (2019-2024)
6.3 Global Irritable Bowel Syndrome (IBS) Market Size Market Share by Type (2019-2024)
6.4 Global Irritable Bowel Syndrome (IBS) Price by Type (2019-2024)
7 Irritable Bowel Syndrome (IBS) Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Irritable Bowel Syndrome (IBS) Market Sales by Application (2019-2024)
7.3 Global Irritable Bowel Syndrome (IBS) Market Size (M USD) by Application (2019-2024)
7.4 Global Irritable Bowel Syndrome (IBS) Sales Growth Rate by Application (2019-2024)
8 Irritable Bowel Syndrome (IBS) Market Segmentation by Region
8.1 Global Irritable Bowel Syndrome (IBS) Sales by Region
8.1.1 Global Irritable Bowel Syndrome (IBS) Sales by Region
8.1.2 Global Irritable Bowel Syndrome (IBS) Sales Market Share by Region
8.2 North America
8.2.1 North America Irritable Bowel Syndrome (IBS) Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Irritable Bowel Syndrome (IBS) Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Irritable Bowel Syndrome (IBS) Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Irritable Bowel Syndrome (IBS) Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Irritable Bowel Syndrome (IBS) Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Key Companies Profile
9.1 Bausch Health
9.1.1 Bausch Health Irritable Bowel Syndrome (IBS) Basic Information
9.1.2 Bausch Health Irritable Bowel Syndrome (IBS) Product Overview
9.1.3 Bausch Health Irritable Bowel Syndrome (IBS) Product Market Performance
9.1.4 Bausch Health Business Overview
9.1.5 Bausch Health Irritable Bowel Syndrome (IBS) SWOT Analysis
9.1.6 Bausch Health Recent Developments
9.2 Allergan
9.2.1 Allergan Irritable Bowel Syndrome (IBS) Basic Information
9.2.2 Allergan Irritable Bowel Syndrome (IBS) Product Overview
9.2.3 Allergan Irritable Bowel Syndrome (IBS) Product Market Performance
9.2.4 Allergan Business Overview
9.2.5 Allergan Irritable Bowel Syndrome (IBS) SWOT Analysis
9.2.6 Allergan Recent Developments
9.3 Takeda
9.3.1 Takeda Irritable Bowel Syndrome (IBS) Basic Information
9.3.2 Takeda Irritable Bowel Syndrome (IBS) Product Overview
9.3.3 Takeda Irritable Bowel Syndrome (IBS) Product Market Performance
9.3.4 Takeda Irritable Bowel Syndrome (IBS) SWOT Analysis
9.3.5 Takeda Business Overview
9.3.6 Takeda Recent Developments
9.4 Sucampo Pharmaceuticals (Mallinckrodt)
9.4.1 Sucampo Pharmaceuticals (Mallinckrodt) Irritable Bowel Syndrome (IBS) Basic Information
9.4.2 Sucampo Pharmaceuticals (Mallinckrodt) Irritable Bowel Syndrome (IBS) Product Overview
9.4.3 Sucampo Pharmaceuticals (Mallinckrodt) Irritable Bowel Syndrome (IBS) Product Market Performance
9.4.4 Sucampo Pharmaceuticals (Mallinckrodt) Business Overview
9.4.5 Sucampo Pharmaceuticals (Mallinckrodt) Recent Developments
9.5 Sebela Pharmaceuticals Inc
9.5.1 Sebela Pharmaceuticals Inc Irritable Bowel Syndrome (IBS) Basic Information
9.5.2 Sebela Pharmaceuticals Inc Irritable Bowel Syndrome (IBS) Product Overview
9.5.3 Sebela Pharmaceuticals Inc Irritable Bowel Syndrome (IBS) Product Market Performance
9.5.4 Sebela Pharmaceuticals Inc Business Overview
9.5.5 Sebela Pharmaceuticals Inc Recent Developments
9.6 Astellas Pharmaceuticals
9.6.1 Astellas Pharmaceuticals Irritable Bowel Syndrome (IBS) Basic Information
9.6.2 Astellas Pharmaceuticals Irritable Bowel Syndrome (IBS) Product Overview
9.6.3 Astellas Pharmaceuticals Irritable Bowel Syndrome (IBS) Product Market Performance
9.6.4 Astellas Pharmaceuticals Business Overview
9.6.5 Astellas Pharmaceuticals Recent Developments
10 Irritable Bowel Syndrome (IBS) Market Forecast by Region
10.1 Global Irritable Bowel Syndrome (IBS) Market Size Forecast
10.2 Global Irritable Bowel Syndrome (IBS) Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Irritable Bowel Syndrome (IBS) Market Size Forecast by Country
10.2.3 Asia Pacific Irritable Bowel Syndrome (IBS) Market Size Forecast by Region
10.2.4 South America Irritable Bowel Syndrome (IBS) Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Irritable Bowel Syndrome (IBS) by Country
11 Forecast Market by Type and by Application (2025-2030)
11.1 Global Irritable Bowel Syndrome (IBS) Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Irritable Bowel Syndrome (IBS) by Type (2025-2030)
11.1.2 Global Irritable Bowel Syndrome (IBS) Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Irritable Bowel Syndrome (IBS) by Type (2025-2030)
11.2 Global Irritable Bowel Syndrome (IBS) Market Forecast by Application (2025-2030)
11.2.1 Global Irritable Bowel Syndrome (IBS) Sales (Kilotons) Forecast by Application
11.2.2 Global Irritable Bowel Syndrome (IBS) Market Size (M USD) Forecast by Application (2025-2030)
12 Conclusion and Key Findings

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings